Penelope M. Webb

ORCID: 0000-0003-0733-5930
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian cancer diagnosis and treatment
  • Cancer Risks and Factors
  • Endometriosis Research and Treatment
  • Endometrial and Cervical Cancer Treatments
  • BRCA gene mutations in cancer
  • Cancer-related molecular mechanisms research
  • Cancer, Lipids, and Metabolism
  • Genetic Associations and Epidemiology
  • Helicobacter pylori-related gastroenterology studies
  • Nutrition, Genetics, and Disease
  • Cancer survivorship and care
  • Vitamin D Research Studies
  • Esophageal Cancer Research and Treatment
  • Estrogen and related hormone effects
  • Nutritional Studies and Diet
  • RNA modifications and cancer
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Epigenetics and DNA Methylation
  • Childhood Cancer Survivors' Quality of Life
  • Eosinophilic Esophagitis
  • Reproductive Biology and Fertility
  • Gastroesophageal reflux and treatments
  • Global Public Health Policies and Epidemiology
  • Family Support in Illness

QIMR Berghofer Medical Research Institute
2016-2025

The University of Queensland
2016-2025

Fox Chase Cancer Center
2024

Peter MacCallum Cancer Centre
2010-2023

Cancer Australia
2010-2023

Harvard University
2004-2023

Ovarian Cancer Research Alliance
2009-2023

Novartis (Switzerland)
2023

Jazz Pharmaceuticals (United States)
2023

Karyopharm Therapeutics (United States)
2023

The frequency of BRCA1 and BRCA2 germ-line mutations in women with ovarian cancer is unclear; reports vary from 3% to 27%. impact mutation on response requires further investigation understand its treatment planning clinical trial design.Women nonmucinous carcinoma (n = 1,001) enrolled onto a population-based, case-control study were screened for point large deletions both genes. Survival outcomes responses multiple lines chemotherapy assessed.Germ-line found 14.1% patients overall,...

10.1200/jco.2011.39.8545 article EN Journal of Clinical Oncology 2012-06-19

The cross sectional study describes the prevalence of infection with Helicobacter pylori as determined by a serodiagnostic assay in over 3000 asymptomatic subjects, two age groups 25-34 years and 55-64 years, from 17 geographically defined populations Europe, North Africa, America, Japan, using common protocol for blood collection serological testing. In all combined, was higher older group (62.4%) than younger (34.9%). There no difference between men women. Subjects education had...

10.1136/gut.34.12.1672 article EN Gut 1993-12-01

<h3>Abstract</h3> <b>Abstract Objectives</b> : To relate the prevalence of infection with Helicobacter pylori in adults to their living conditions childhood indentify risk factors for infection. <b>Design</b> Prevalence study IgG antibodies H (&gt;10 μg IgG/ml, determined by enzyme linked immunosorbent assay (ELISA)) and reported other socioeconomic childhood. <b>Setting</b> Three factories Stoke on Trent. <b>Subjects</b> 471 male volunteers aged 18 65 years. <b>Main outcome measures</b>...

10.1136/bmj.308.6931.750 article EN BMJ 1994-03-19

Cancer is a leading cause of disease burden in Australia, particularly fatal burden, accounting for an estimated thirty percent deaths. Many cancers develop because exposure to lifestyle and environmental factors that are potentially modifiable. We aimed quantify the proportions numbers cancer deaths cases Australia 2013 attributable 20 modifiable eight broad groupings established causes cancer, namely: tobacco smoke (smoking second‐hand), dietary (low intake fruit, non‐starchy vegetables...

10.1002/ijc.31088 article EN International Journal of Cancer 2017-10-06

10.1038/ng.668 article EN Nature Genetics 2010-09-19

To measure the relative risks of adenocarcinomas oesophagus and gastro-oesophageal junction associated with measures obesity, their interactions age, sex, reflux symptoms smoking.Population-based case-control study in Australia.Patients (n = 367) or 426) were compared control participants 1580) sampled from a population register.Relative risk adenocarcinoma junction.Risks oesophageal increased monotonically body mass index (BMI) (p(trend) <0.001). Highest seen for BMI >or=40 kg/m2 (odds...

10.1136/gut.2007.131375 article EN Gut 2007-10-11

Previous studies that showed an association between smoking and adenocarcinomas of the esophagus esophagogastric junction were limited in their ability to assess differences by tumor site, sex, dose-response, duration cigarette cessation.We used primary data from 10 population-based case-control two cohort Barrett's Esophagus Esophageal Adenocarcinoma Consortium. Analyses restricted white non-Hispanic men women. Patients classified as having esophageal adenocarcinoma (n = 1540), junctional...

10.1093/jnci/djq289 article EN JNCI Journal of the National Cancer Institute 2010-08-17

10.1038/ng.424 article EN Nature Genetics 2009-08-02

Abstract Accurately identifying patients with high-grade serous ovarian carcinoma (HGSOC) who respond to poly(ADP-ribose) polymerase inhibitor (PARPi) therapy is of great clinical importance. Here we show that quantitative BRCA1 methylation analysis provides new insight into PARPi response in preclinical models and cancer patients. The 12 HGSOC patient-derived xenografts (PDX) the rucaparib was assessed, variable dose-dependent responses observed chemo-naive BRCA1/2 -mutated PDX, no PDX...

10.1038/s41467-018-05564-z article EN cc-by Nature Communications 2018-09-24

Whilst previous studies have reported that higher BMI increases a woman's risk of developing ovarian cancer, associations for the different histological subtypes not been well defined. As prevalence obesity has increased dramatically, and classification histology improved in last decade, we sought to examine association pooled analysis recent participating Ovarian Cancer Association Consortium. We evaluated between (recent, maximum young adulthood) cancer using original data from 15...

10.1530/erc-12-0395 article EN Endocrine Related Cancer 2013-02-12

Clinicopathologic data from a population-based endometrial cancer cohort, unselected for age or family history, were analyzed to determine the optimal scheme identification of patients with germline mismatch repair (MMR) gene mutations.Endometrial cancers 702 recruited into Australian National Endometrial Cancer Study (ANECS) tested MMR protein expression using immunohistochemistry (IHC) and MLH1 promoter methylation in MLH1-deficient cases. mutation testing was performed on DNA MMR-protein...

10.1200/jco.2013.51.2129 article EN Journal of Clinical Oncology 2013-12-10

Abstract Objective To investigate whether supplementing older adults with monthly doses of vitamin D alters the incidence major cardiovascular events. Design Randomised, double blind, placebo controlled trial (the D-Health Trial). Computer generated permuted block randomisation was used to allocate treatments. Setting Australia from 2014 2020. Participants 21 315 participants aged 60-84 years at enrolment. Exclusion criteria were self-reported hypercalcaemia, hyperparathyroidism, kidney...

10.1136/bmj-2023-075230 article EN cc-by-nc BMJ 2023-06-28

Abstract Chronic inflammation has been proposed as the possible causal mechanism that explains observed association between certain risk factors, such use of talcum powder (talc) in pelvic region and epithelial ovarian cancer. To address this issue we evaluated potential role chronic local development major subtypes Factors potentially linked to were examined an Australia‐wide case–control study comprising 1,576 women with invasive low malignant (LMP) tumours 1,509 population‐based controls....

10.1002/ijc.23017 article EN International Journal of Cancer 2007-08-25
Coming Soon ...